167 related articles for article (PubMed ID: 23893384)
1. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma.
Hu F; Tao Z; Wang M; Li G; Zhang Y; Zhong H; Xiao H; Xie X; Ju M
Tumour Biol; 2013 Dec; 34(6):3893-9. PubMed ID: 23893384
[TBL] [Abstract][Full Text] [Related]
2. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of S-adenosylhomocysteine hydrolase (SAHH) in esophageal squamous cell carcinoma (ESCC) cell lines: effects on apoptosis, migration and adhesion of cells.
Li Q; Mao L; Wang R; Zhu L; Xue L
Mol Biol Rep; 2014; 41(4):2409-17. PubMed ID: 24430301
[TBL] [Abstract][Full Text] [Related]
4. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.
Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q
J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523
[TBL] [Abstract][Full Text] [Related]
5. RAP1B, a DVL2 binding protein, activates Wnt/beta-catenin signaling in esophageal squamous cell carcinoma.
Jia Z; Yang Y; Dengyan Z; Chunyang Z; Donglei L; Kai W; Song Z
Gene; 2017 May; 611():15-20. PubMed ID: 28119087
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between RACK1 expression and clinicopathologic information of esophageal squamous cell carcinoma].
Wang ZY; Chen ZL; Feng M; Shi SS; He J; Dai GH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1397-400. PubMed ID: 21756811
[TBL] [Abstract][Full Text] [Related]
7. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
Li Z; Jin H; Mao G; Wu L; Guo Q
Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2.
Zhang JX; Chen ZH; Xu Y; Chen JW; Weng HW; Yun M; Zheng ZS; Chen C; Wu BL; Li EM; Fu JH; Ye S; Xie D
Clin Cancer Res; 2017 Jan; 23(1):298-310. PubMed ID: 27407092
[TBL] [Abstract][Full Text] [Related]
9. AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression.
Shi X; Chen Z; Hu X; Luo M; Sun Z; Li J; Shi S; Feng X; Zhou C; Li Z; Yang W; Li Y; Wang P; Zhou F; Gao Y; He J
Oncotarget; 2016 Jun; 7(24):36407-36418. PubMed ID: 27172796
[TBL] [Abstract][Full Text] [Related]
10. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
[TBL] [Abstract][Full Text] [Related]
11. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
12. RACK1 promotes radiation resistance in esophageal cancer via regulating AKT pathway and Bcl-2 expression.
Liu B; Wang C; Chen P; Wang L; Cheng Y
Biochem Biophys Res Commun; 2017 Sep; 491(3):622-628. PubMed ID: 28760343
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity.
Hu F; Tao Z; Shen Z; Wang X; Hua F
Tumour Biol; 2014 Jul; 35(7):7225-32. PubMed ID: 24771266
[TBL] [Abstract][Full Text] [Related]
14. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
15. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
[TBL] [Abstract][Full Text] [Related]
16. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma.
Jiang W; Yao F; He J; Lv B; Fang W; Zhu W; He G; Chen J; He J
Tumour Biol; 2015 Feb; 36(2):1289-97. PubMed ID: 25352025
[TBL] [Abstract][Full Text] [Related]
19. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway.
Zou S; Yang J; Guo J; Su Y; He C; Wu J; Yu L; Ding WQ; Zhou J
Cancer Lett; 2018 Mar; 417():65-74. PubMed ID: 29306013
[TBL] [Abstract][Full Text] [Related]
20. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.
Cui XB; Li S; Li TT; Peng H; Jin TT; Zhang SM; Liu CX; Yang L; Shen YY; Li SG; Li N; Li Y; Hu JM; Jiang JF; Suo J; Qi Y; Liang WH; Wang LH; Dang HW; Li L; Cao WW; Wei Y; Laibo-Yin ; Wu CY; Yuan XL; Zhou H; Zheng Y; Chen YZ; Li F
Oncotarget; 2016 Jan; 7(2):1777-95. PubMed ID: 26657507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]